Astellas Pharma Inc. - Other Stockholder Equity

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Other-Stockholder-Equity" stands at 147.62 Billion Japanese Yens as of 06/30/2025.

As of the end of Astellas Pharma Inc.'s first quarter, the item "Other Stockholder Equity" stands at 147.62 Billion JPY. This represents a decrease of -0.08 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.56 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 3.56 Billion Japanese Yens.
The 3 year change is -8.05 Billion Japanese Yens.
The 5 year change is -22.14 Billion Japanese Yens.
The 10 year change is 29.08 Billion Japanese Yens.

The Serie's long term average value is 106.63 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 40.99 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 12/31/2011, to it's latest available value, on 06/30/2025, is +172.11 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2019, to it's latest available value, on 06/30/2025, is -24.85 Billion.